Naing Aay, San Mateo, CA (US); G. Leslie Burnett, Redwood City, CA (US); James Cregg, Belmont, CA (US); Adrian L. Gill, Atherton, CA (US); John E. Knox, Emerald Hills, CA (US); Elena S. Koltun, Foster City, CA (US); Yang Liu, Foster City, CA (US); Andreas Buckl, San Francisco, CA (US); Bianca Jennifer Lee, Redwood City, CA (US); David E. Wildes, San Francisco, CA (US); Meghan A. Rice, Belmont, CA (US); and Mallika Singh, San Francisco, CA (US)
Assigned to Revolution Medicines, Inc., Redwood City, CA (US)
Filed by Revolution Medicines, Inc., Redwood City, CA (US)
Filed on Sep. 15, 2021, as Appl. No. 17/476,269.
Claims priority of provisional application 63/192,775, filed on May 25, 2021.
Claims priority of provisional application 63/184,412, filed on May 5, 2021.
Claims priority of provisional application 63/129,231, filed on Dec. 22, 2020.
Claims priority of provisional application 63/078,802, filed on Sep. 15, 2020.
Prior Publication US 2022/0105185 A1, Apr. 7, 2022
